Professor of Surgery

Contact Info Peter Stock, MD, Ph.D. Surgery Department 505 Parnassus, Box 0780, M884 San Francisco, CA 94143 Tel: (415) 353-1551 Fax: (415) 353-8794 Email: stockp@surgery.ucsf.ed

Peter Stock is Professor of Surgery and heads up the solid organ pancreas transplant program as well as pancreatic islet cell program. He was trained at the University of Minnesota, completing a surgical residency before coming to UCSF for a transplant fellowship. He joined the UCSF faculty in 1992. A frequent presenter on issues related to transplantation and immunosuppression, he is an active teacher and supervisor of surgical residents and fellows. He holds membership in numerous professional and honorary societies. Stock is clinically active in liver, kidney and pancreas transplantation. Stock’s current basic science research interests involve the induction of transplantation tolerance to block both alloimmunity as well as recurrent autoimmunity following pancreatic islet transplantation. On a clinical level, results from these studies can be directly applied to the protection of human pancreatic islets following transplantation into diabetic recipients. Finally, he is the principal investigator on a study to determine the safety and efficacy of solid organ transplantation in the HIV positive recipient.

Selected Publications:

Kang, SM; Schneider, D; Lin, Z; Hanahan, D; Stock, PG; Baekkeskov, S. 1997. Fas Ligand expression in islets does not confer immune privilege and instead targets them for rapid destruction. Nature Medicine; 3(7):738-743, 1997.

O'Rourke RW, Kang SM, Lower JA, Feng S, Ascher NL, Baekkeskov S, Stock PG. A Dendritic Cell Line Genetically Modified to Express CTLA4-Ig as a Means to Prolong Islet Allograft Survival. Transplantation, 2000 Apr 15, 69(7):1440-6. (UI:20256626)

Kang SM, Braat D, Schneider DB, O'Rourke RW, Lin Z, Ascher NL, Dichek DA, Baekkeskov S, Stock PG. A Non-Cleavable Mutant of Fas Ligand Does Not Prevent Neutrophilic Destruction of Islet Transplants. Transplantation, 2000 May 15, 69(9):1813-7. (UI:20289028)

George J. Chang, MD, Tao Liu, MD, Sandy Feng, MD, PhD, Melanie Bedolli, BS, Robert W. O’Rourke, MD, Gregory Schmidt, BS, John P. Roberts, MD, and Peter G. Stock, MD, PhD. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery 2002; 132(2), 149-156.

Roland, ME, Stock, P. Review of Solid Organ Transplantation in HIV-Infected Patients. Transplantation. Volume 75(4): 425